Career Enhancement Program
Career Enhancement Program
批准号:
10494113
负责人:
KEVIN M. SHANNON
金额:
$9.39万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
未结题
起止时间:
2015-09-01 至 2026-08-31
关键词:
AccelerationAddressAreaAwardBasic ScienceCaliforniaCancer BiologyCancer CenterChildClinicalClinical InvestigatorClinical SciencesCommunicationCommunitiesDataDevelopmentDisciplineDiseaseEducationEnsureExtramural ActivitiesFacultyFeedbackFoundationsFundingFunding OpportunitiesFutureGoalsHealth SciencesHistorically Black Colleges and UniversitiesHumanHuman DevelopmentIndianaIndividualInfrastructureInstitutionInternationalKnowledgeLeadershipLinkMalignant NeoplasmsMemorial Sloan-Kettering Cancer CenterMentorsMentorshipMissionMonitorMutationNF1 geneNF1 mutationNational Cancer InstituteNatureNeurofibromatosesPathologyPediatric HospitalsPediatric OncologyPediatric Oncology GroupPhiladelphiaPre-Clinical ModelProcessProfessional OrganizationsProgram DevelopmentRequest for ApplicationsResearchResearch PersonnelResourcesRoleSan FranciscoScheduleScienceScientistSex OrientationSignal TransductionSiteSocietiesStructureTalentsTexasTextilesTherapeuticTherapeutic TrialsTrainingTraining ProgramsTranslational ResearchUnderrepresented MinorityUnderrepresented PopulationsUniversitiesWorkanticancer researchbasecancer therapycareercareer developmentclinical outcome assessmentclinical translationdesigndevelopmental diseasedisabilityearly-career facultyeffective therapyefficacy validationfaculty supporthyperactive Rasinnovationinstructormeetingsmemberminority investigatorneoplasm therapyneuro-oncologynext generationpharmacokinetics and pharmacodynamicspreclinical studyprofessorprogramsracial and ethnicrecruitsenior facultyskillssuccesstranslational scientisttumor
中文摘要
抽象-职业提升计划
DHART孢子职业提升计划(CEP)支持讲师和助理的教员
教授水平,从事翻译研究,重点是NF1/类风湿疾病和癌症。这个
CEP的主要目标是促进正在开发创新能力的早期调查人员的职业生涯
与为癌症实施更有效和毒性更低疗法的目标有关的研究
由NF1/RAS。这种孢子的多机构性质利用了一大批有才华的早期职业
来自多个学科的教师。每个机构都将CEP视为招募和推进
早期翻译科学家的职业生涯。他们总共承诺了130万美元用于目前的
奖励和165万美元用于支持达特孢子发展计划(CEP)的更新
和DRP)。CEP的具体目标是:(1)支持早期调查人员的发展
创新研究计划,为NF1相关癌症研究贡献新知识,同时产生
(2)提供早期阶段的初步数据,使今后能够成功地获得独立的外部资金;
为研究人员提供培训,使他们具备独立取得成功所需的基本技能和知识
研究人员;以及,(3)通过定期安排的一对一指导早期翻译研究人员
导师会议和结构化的个人发展计划(IDP),以促进与交换矩阵的集成
孢子的种类。执行委员会特别强调支持招募任职人数偏低的少数群体。
调查人员(URM)。达哈特孢子将在垂直和水平上与所有
财团机构,并确保最大限度地利用CEP的指导和供资机会
在七个Dhart孢子遗址上进行了URM。此外,应用程序请求(RFA)将与
历史上,黑人学院和大学以及代表以下社区的专业组织-
在生物医学科学中具有代表性。RFA已经通过DHART孢子站点发送到外部
儿童肿瘤基金会和神经纤维瘤病治疗加速计划。我们正在扩张
这项招募工作包括神经肿瘤学学会、美国Rasopathies网络、儿童
肿瘤学小组。目标是每年资助两个CEP提案(每个提案50,000-75,000美元)。申请
申请将每年公布两次,通过广泛的沟通,所有上述小组,以最大限度地
为招募不同的科学家和科学提供机会。CEP机会也将在以下会议上重点介绍
全年专业会议。CEP支持的申请将通过
竞争过程,由参议员组成的发展计划指导委员会进行审查
来自达特孢子的科学家在孢子外部和内部的监督和指导下
顾问委员会。
英文摘要
ABSTRACT– CAREER ENCHANCEMENT PROGRAM
The DHART SPORE Career Enhancement Program (CEP) supports faculty at the Instructor and Assistant
Professor levels to engage in translational research focused on NF1/Rasopathy disorders and cancer. The
primary goal of the CEP is to advance the careers of early stage investigators who are developing innovative
research related to the goal of implementing more effective and less toxic therapies for cancers characterized
by NF1/Ras. The multi-institutional nature of this SPORE leverages a large and talented pool of early career
faculty from multiple disciplines. Each institution views the CEP as a vehicle for recruiting and advancing the
careers of early stage translational scientists. Collectively, they have committed $1.3 million to the current
award and $1.65 million to the renewal to support the Developmental Programs of the DHART SPORE (CEP
and DRP). The Specific Aims of the CEP are to: (1) support early stage investigators as they develop
innovative research programs that contribute new knowledge to NF1-related cancer research while generating
preliminary data that will allow successful future independent extramural funding; (2) provide early stage
researchers with training that will equip them with essential skills and knowledge for success as independent
investigators; and, (3) mentor early stage translational researchers through regularly scheduled one-on-one
mentor meetings and a structured Individual Development Program (IDP) to facilitate integration into the fabric
of the SPORE. The CEP has a special emphasis on supporting the recruitment of underrepresented minority
investigators (URM). The DHART SPORE will link vertically and horizontally with diversity programs at all of
the consortium institutions and ensure maximum exposure of the CEP mentorship and funding opportunities to
URM across the seven DHART SPORE sites. Further, requests for applications (RFA) will be shared with
Historically Black Colleges and Universities and professional organizations representing communities under-
represented in biomedical science. RFAs are already sent outside of the DHART SPORE sites via the
Children’s Tumor Foundation and Neurofibromatosis Therapeutic Acceleration Program. We are expanding
this recruitment effort to include the Society for Neuro-Oncology, RASopathies Network USA, the Children’s
Oncology Group. The goal is to fund two CEP proposals per year ($50,000 - $75,000/proposal). Requests for
applications will be announced twice a year via broad communications to all groups listed above to maximize
opportunities for recruitment of diverse scientists and science. CEP opportunities will also be highlighted at
professional meetings throughout the year. Applications for CEP support will be evaluated through a
competitive process with review by a Developmental Programs Steering Committee comprised of senor
scientists from the DHART SPORE with oversight and guidance from the SPORE External and Internal
Advisory Boards.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
In Vivo Functional Analysis of Chromosome 7q22 Deletions in Myeloid Malignancies
-
批准号:9924474
-
项目类别:
-
资助金额:$33.87万
-
财政年份:2017
-
负责人:KEVIN M. SHANNON
-
依托单位:
Selectively Targeting Oncogenic NRAS in Cancer
-
批准号:10372214
-
项目类别:
-
资助金额:$50.61万
-
财政年份:2015
-
负责人:KEVIN M. SHANNON
-
依托单位:
Project 3: Efficacy of MEK Inhibition in Juvenile Myelomonocytic Leukemia
-
批准号:8932164
-
项目类别:
-
资助金额:$43.13万
-
财政年份:2015
-
负责人:KEVIN M. SHANNON
-
依托单位:
Selectively Targeting Oncogenic NRAS in Cancer
-
批准号:10209682
-
项目类别:
-
资助金额:$53.18万
-
财政年份:2015
-
负责人:KEVIN M. SHANNON
-
依托单位:
Developmental Research Program
-
批准号:8932166
-
项目类别:
-
资助金额:$10.45万
-
财政年份:2015
-
负责人:KEVIN M. SHANNON
-
依托单位:
Selectively Targeting Oncogenic NRAS in Cancer
-
批准号:9040123
-
项目类别:
-
资助金额:$55.05万
-
财政年份:2015
-
负责人:KEVIN M. SHANNON
-
依托单位:
Selectively Targeting Oncogenic NRAS in Cancer
-
批准号:10610346
-
项目类别:
-
资助金额:$50.61万
-
财政年份:2015
-
负责人:KEVIN M. SHANNON
-
依托单位:
Developmental Research Program
-
批准号:10494111
-
项目类别:
-
资助金额:$9.39万
-
财政年份:2015
-
负责人:KEVIN M. SHANNON
-
依托单位:
Career Development Program
-
批准号:8932167
-
项目类别:
-
资助金额:$10.45万
-
财政年份:2015
-
负责人:KEVIN M. SHANNON
-
依托单位:
PROJECT 3: A High Content Clinical Trial of the MEK inhibitor Trametinib in JMML
-
批准号:10270583
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2015
-
负责人:KEVIN M. SHANNON
-
依托单位:
PROJECT 3: A High Content Clinical Trial of the MEK inhibitor Trametinib in JMML
-
批准号:10494109
-
项目类别:
-
资助金额:$37.55万
-
财政年份:2015
-
负责人:KEVIN M. SHANNON
-
依托单位:
Selectively Targeting Oncogenic NRAS in Cancer
-
批准号:9278130
-
项目类别:
-
资助金额:$49.7万
-
财政年份:2015
-
负责人:KEVIN M. SHANNON
-
依托单位:
Developmental Research Program
-
批准号:10270584
-
项目类别:
-
资助金额:$9.02万
-
财政年份:2015
-
负责人:KEVIN M. SHANNON
-
依托单位:
Career Enhancement Program
-
批准号:10270585
-
项目类别:
-
资助金额:$9.02万
-
财政年份:2015
-
负责人:KEVIN M. SHANNON
-
依托单位:
(PQD1) Response and Resistance to Inhibitors of Ras Effectors in Blood Cancers
-
批准号:8895286
-
项目类别:
-
资助金额:$32.89万
-
财政年份:2013
-
负责人:KEVIN M. SHANNON
-
依托单位:
(PQD1) Response and Resistance to Inhibitors of Ras Effectors in Blood Cancers
-
批准号:9112921
-
项目类别:
-
资助金额:$32.89万
-
财政年份:2013
-
负责人:KEVIN M. SHANNON
-
依托单位:
(PQD1) Response and Resistance to Inhibitors of Ras Effectors in Blood Cancers
-
批准号:8590462
-
项目类别:
-
资助金额:$32.59万
-
财政年份:2013
-
负责人:KEVIN M. SHANNON
-
依托单位:
(PQD1) Response and Resistance to Inhibitors of Ras Effectors in Blood Cancers
-
批准号:8735906
-
项目类别:
-
资助金额:$31.81万
-
财政年份:2013
-
负责人:KEVIN M. SHANNON
-
依托单位:
ID OF MOLECULES THAT SUBSTITUTE FOR ACTIVE NOTCH1 IN T LINEAGE LEUKEMOGENESIS
-
批准号:8363842
-
项目类别:
-
资助金额:$0.23万
-
财政年份:2011
-
负责人:KEVIN M. SHANNON
-
依托单位:
Myeloid Tumor Suppressor Gene Discovery from Chromosome Band 7q22
-
批准号:8319537
-
项目类别:
-
资助金额:$43.4万
-
财政年份:2011
-
负责人:KEVIN M. SHANNON
-
依托单位:
海外基金